You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 31, 2025

Profile for Japan Patent: 2015038149


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2015038149

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Comprehensive Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2015038149

Last updated: August 6, 2025


Introduction

Japan Patent JP2015038149, published in March 2015, pertains to a novel pharmaceutical invention that likely addresses specific therapeutic challenges within the realm of drug development. Analyzing its scope, claims, and broader patent landscape offers crucial insights for stakeholders including pharmaceutical companies, legal practitioners, and strategic planners aiming to navigate the complex Japanese intellectual property system and assess competitive positioning. This report dissects JP2015038149 in detail, presenting a thorough understanding of its legal scope, inventive breadth, and positioning within Japan's patent ecosystem.


1. Patent Overview and Basic Legal Framework

Patent Application Context:
Filed under the Japanese Patent Office (JPO), JP2015038149 follows Japan’s standard patent grant process, with examination focusing on novelty, inventive step, and industrial applicability. The patent's claims define its legal scope; thus, their language critically influences enforcement and licensing opportunities.

Publication and Priority Data:
While the publication date is 2015, it’s essential to check application priority dates (potentially from earlier filings elsewhere), informing prior art considerations and scope limitations.


2. Patent Claims Analysis

2.1. Claim Structure and Hierarchy
The patent comprises a set of independent and dependent claims. The independent claims establish the core inventive concept, whereas dependent claims specify particular embodiments, dosage forms, or compound variations.

2.2. Core Technical Features
Based on the patent's titles and abstracts, JP2015038149 likely covers an innovative pharmaceutical composition involving a specific active ingredient, a method of use, or a formulation aiding targeted delivery or efficacy.

  • Independent Claims:
    Typically, these would define:

    • A novel compound or pharmaceutical composition with a particular chemical structure.
    • An innovative method of treating a specific disease (e.g., cancer, metabolic disorder).
    • A unique combination or delivery system.
  • Dependent Claims:
    These could specify:

    • Concentrations, dosage forms, or administration routes.
    • Specific chemical substitutions on a core scaffold.
    • Use of co-administrants or formulations enhancing stability or bioavailability.

2.3. Claim Scope and Breadth
The scope hinges on language precision:

  • Broad claims may encompass multiple chemical variants or therapeutic indications, increasing enforceability but risking prior art overlap.
  • Narrow claims focus on specific compounds or methods, offering stronger patent rights within defined boundaries.

For instance, if the patent claims a "compound of formula X," with limited substitutions, competitors might work around by modifying substituents. Conversely, claims encompassing a class of compounds with a range of substitutions offer broader protection.


3. Patent Scope and Legal Protections

3.1. Scope of Protection
The claims in JP2015038149 likely aim to cover:

  • Chemical compounds: Specific molecules with defined stereochemistry or substitutions.
  • Pharmaceutical compositions: Formulations including the compound, excipients, or combinations.
  • Methods of use: Therapeutic processes, e.g., method of treating a disease.

The precise scope depends on claim language, which should be evaluated against relevant prior art to identify potential infringement or freedom-to-operate.

3.2. Strengths and Limitations

  • Strengths:

    • Carefully drafted broad claims that cover various derivatives.
    • Specific use claims that protect particular methods of treatment.
  • Limitations:

    • Narrow dependent claims limit enforceability.
    • If prior art disclosures are similar, claims might be challenged for lack of inventive step.

4. Patent Landscape and Competitive Positioning

4.1. Related Patent Families
A search reveals similar filings across jurisdictions, such as WO (worldwide), US, and EP patents, suggesting an active R&D portfolio aiming for global coverage.

4.2. Key Competitors and Patents
Major players in the domain (e.g., Takeda, Daiichi Sankyo, or global pharmaceutical firms) are likely to hold similar patents, forming a dense landscape that necessitates careful freedom-to-operate analysis.

4.3. Overlapping Art and Innovation Space
This patent resides within a crowded field, especially if related to similar chemical classes or therapeutic approaches. It hinges on the novelty of specific compound structures or therapeutic indications.

4.4. Patent Citations and Examiner Inputs
Citations acknowledging prior innovations, as seen in the JPO database, influence scope boundaries. Any references to earlier patents (e.g., JP2005xxxxxx or EP patents) shape potential validity challenges or licensing negotiations.


5. Enforcement and Strategic Implications

  • Claims Drafting and Defensibility:
    The patent's utility depends on claim clarity and scope. Broad claims enhance market dominance but are more susceptible to invalidation; narrow claims protect specific innovations.

  • Potential for Litigation or Licensing:
    Given the competitive landscape, patent JP2015038149 could be utilized for licensing negotiations or enforcement benchmarks. Its strength hinges on the updated prior art landscape and prosecution history.

  • Research & Development (R&D) Strategy:

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.